Cardio Diagnostics Holdings, Inc. SEC filings CDIOW

Cardio Diagnostics Holdings, Inc. has 295 filings in SEC EDGAR's recent list, going back to Jul 20, 2021. Its latest annual report, Form ARS, was filed on Jul 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 18, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-Q Quarterly report Nov 7, 2022 Sep 30, 2022
10-Q Quarterly report Aug 10, 2022 Jun 30, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
CDIO (Nasdaq), CDIOW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Chicago, IL
SEC filer status
, Emerging growth company
SEC CIK
1870144
Former names
Mana Capital Acquisition Corp. (until Oct 26, 2022)

Other In Vitro & In Vivo Diagnostic Substances companies

All 21 In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.